OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 09, 2021
A picture of wide manufacturing violations appears in a recently disclosed FDA form 483 report on a site visit to Emergent’s Baltimore vaccine plant.
April 06, 2021
André Sode, CEO of Liva Healthcare, talks about Liva’s collaboration with Amgen to co-create an innovative digital tele-rehabilitation solution called Rehab+.
April 01, 2021
Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.
March 31, 2021
Healthcare providers across Canada will be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum.
This month brings the IR35 tax reform on the UK’s private sector. How will it affect the pharma industry?
March 30, 2021
New product expands outreach of medical affairs organizations.
March 24, 2021
A coalition of biopharma and technology leaders have announced a new strategic collaboration to promote new and updated standards for advanced therapies.
Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained.
March 18, 2021
Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
March 17, 2021
Federal Trade Commission to launch a broad review of drug-company mergers.
March 10, 2021
New initiative from late-stage research and patient-support services organization aims to accelerate COVID-19 vaccine development.
March 04, 2021
MassBio’s latest Biopharma Funding Report shows Massachusetts biopharma companies raised record-breaking $5.8 billion in VC Funding in 2020.
February 11, 2021
FDA accepted Impel’s new drug application (NDA) for TRUDHESA last month.
January 26, 2021
Report highlights how lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely as the pandemic continues.
January 19, 2021
Week-long event aims to help commercialize innovations to reach patients in need.
January 08, 2021
Panel will provide guidance around evolving digital business models.
January 07, 2021
Lead company is seeking others to join the initiative.
January 05, 2021
Mike Hennessey Sr., Chairman and Founder of MJH Life Sciences, pushes for the celebration of the pharmaceutical industry after nine grueling months of fighting COVID-19.
December 18, 2020
Prescription opioid Use in the U.S. has declined by 60% from 2011 Peak, according to new report from IQVIA.